,Table of Contents
b b
Chapter 01: The Nursing Process and Drug Therapy ........................................................................................ 4
b b b b b b b
Chapter 02: Pharmacologic Principles ............................................................................................................. 8
b b b
Chapter 03: Lifespan Considerations ............................................................................................................ 14
b b b
Chapter 04: Cultural, Legal, and Ethical Considerations ................................................................................. 20
b b b b b b
Chapter 05: Medication Errors: Preventing and Responding ......................................................................... 26
b b b b b b
Chapter 06: Patient Education and Drug Therapy .......................................................................................... 29
b b b b b b
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements .................................................. 34
b b b b b b b b
Chapter 08: Gene Therapy and Pharmacogenomics ...................................................................................... 38
b b b b b
Chapter 09: Photo Atlas of Drug Administration ............................................................................................ 41
b b b b b b
Chapter 10: Analgesic Drugs ......................................................................................................................... 50
b b b
Chapter 11: General and Local Anesthetics ................................................................................................... 57
b b b b b
Chapter 12: Central Nervous System Depressants andMuscle Relaxants ...................................................... 61
b b b b b b b b
Chapter 13: Central Nervous System Stimulants and Related Drugs .............................................................. 66
b b b b b b b b
Chapter 14: Antiepileptic Drugs .................................................................................................................... 70
b b b
Chapter 15: Antiparkinson Drugs .................................................................................................................. 76
b b b
Chapter 16: Psychotherapeutic Drugs .......................................................................................................... 81
b b b
Chapter 17: Substance Use Disorder ............................................................................................................. 88
b b b b
Chapter 18: Adrenergic Drugs ....................................................................................................................... 93
b b b
Chapter 19: Adrenergic-Blocking Drugs ........................................................................................................ 98
b b b
Chapter 20: Cholinergic Drugs .................................................................................................................... 103
b b b
Chapter 21: Cholinergic-Blocking Drugs...................................................................................................... 108
b b b
Chapter22: Antihypertensive Drugs ........................................................................................................... 113
b b b
Chapter 23: Antianginal Drugs .................................................................................................................... 119
b b b
Chapter 24: Heart Failure Drugs .................................................................................................................. 125
b b b b
Chapter 25: Antidysrhythmic Drugs ............................................................................................................ 131
b b b
Chapter 26: Coagulation Modifier Drugs ..................................................................................................... 137
b b b b
Chapter 27: Antilipemic Drugs .................................................................................................................... 143
b b b
Chapter 28: Diuretic Drugs .......................................................................................................................... 148
b b b
Chapter 29: Fluids and Electrolytes ............................................................................................................. 154
b b b b
Chapter 30: Pituitary Drugs ......................................................................................................................... 160
b b b
,Chapter 31: Thyroid and Antithyroid Drugs ................................................................................................. 163
b b b b b
Chapter 32: Antidiabetic Drugs ................................................................................................................... 168
b b b
Chapter 33: Adrenal Drugs .......................................................................................................................... 177
b b b
Chapter 34: Women’s Health Drugs ............................................................................................................ 181
b b b b
Chapter 35: Men’s Health Drugs ................................................................................................................. 188
b b b b
Chapter36: Antihistamines, Decongestants, Antitussives, and Expectorants.............................................. 193
b b b b b b
Chapter 37: Respiratory Drugs .................................................................................................................... 198
b b b
Chapter 38: Antibiotics Part 1...................................................................................................................... 204
b b b b
Chapter 39: Antibiotics Part 2...................................................................................................................... 211
b b b b
Chapter 40: Antiviral Drugs ......................................................................................................................... 216
b b b
Chapter 41: Antitubercular Drugs ............................................................................................................... 221
b b b
Chapter 42: Antifungal Drugs ...................................................................................................................... 226
b b b
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ............................................................... 231
b b b b b b
Chapter 44: Anti-inflammatory and Antigout Drugs .................................................................................... 236
b b b b b
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs............................. 242
b b b b b b b b b b b
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs ................ 248
b b b b b b b b b b b
Chapter47: Biologic Response–Modifyingand Antirheumatic Drugs .......................................................... 253
b b b b b b
Chapter 48: Immunosuppressant Drugs ..................................................................................................... 258
b b b
Chapter 49: Immunizing Drugs.................................................................................................................... 263
b b b
Chapter 50: Acid-Controlling Drugs ............................................................................................................ 268
b b b
Chapter 51: Bowel Disorder Drugs .............................................................................................................. 274
b b b b
Chapter 52: Antiemetic and Antinausea Drugs............................................................................................ 281
b b b b b
Chapter 53: Vitamins and Minerals ............................................................................................................. 286
b b b b
Chapter 54: Anemia Drugs .......................................................................................................................... 292
b b b
Chapter 55: Nutritional Supplements ......................................................................................................... 299
b b b
Chapter 56: Dermatologic Drugs ................................................................................................................. 304
b b b
Chapter 57: Ophthalmic Drugs .................................................................................................................... 310
b b b
Chapter 58: Otic Drugs ................................................................................................................................ 315
b b b
, Chapter 01: The Nursing Process and Drug Therapy b b b b b b b b b b 4
Chapter 01: The Nursing Process andDrug Therapy b b b b b b b
MULTIPLE CHOICE b
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been newly
b b b b b b b b b b b b b b b b b b
bdiagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
b b b b b b b b b b b b b
bdiagnosis?
a. Anxiety
b. Anxietyrelated to new drug therapy b b b b b
c. Anxietyrelated to anxious feelings about drug therapy, as evidenced by statements
b b b b b b b b b b b
such as “I’m upset about having to test my blood sugars.”
b b b b b b b b b b b
d. Anxietyrelated to new drug therapy, as evidenced bystatements such as “I’m
b b b b b b b b b b b b
upset about having to test my blood sugars.”
b b b b b b b b
ANS: D b
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is missing the “related
b b b b b b b b b b b b b
to” and “as evidenced by” portions of defining characteristics. “Anxiety related to new drugtherapy”
b b b b b b b b b b b b b b b
is missing the “as evidenced by” portion of defining characteristics. The statement beginning
b b b b b b b b b b b b b
“Anxiety related to anxious feelings” is incorrect because the “related to” section is simply a
b b b b b b b b b b b b b b b
restatement of the problem “anxiety,” not a separate factor related to the response.
b b b b b b b b b b b b b
DIF: COGNITIVE LEVEL: Understanding(Comprehension) b b b
TOP: NURSING PROCESS: Nursing Diagnosis
b b b b b
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
b b b b b b b b b
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy and gave
b b b b b b b b b b b b b b b b b
bthe medication 2 hours after the scheduled dose was due. What type of problem does this represent?
b b b b b b b b b b b b b b b b
a. “Right time” b
b. “Right dose” b
c. “Right route” b
d. “Right medication” b
ANS: A b
“Right time” is correct because the medication was given more than 30 minutes after the scheduled
b b b b b b b b b b b b b b b
dose was due. “Dose” is incorrect because the dose is not related to the time the medication
b b b b b b b b b b b b b b b b b
administration is scheduled. “Route” is incorrect because the route is not affected. “Medication” is
b b b b b b b b b b b b b b
incorrect because the medication ordered will not change.
b b b b b b b b
DIF: COGNITIVE LEVEL: Applying(Application) b b b
TOP: NURSING PROCESS: Implementation
b b b b
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
b b b b b b b b b b
3. The nurse has been monitoring the patient’s progress on a new drug regimen since the first dose and
b b b b b b b b b b b b b b b b b
documenting the patient’s therapeutic response to the medication. Which phase of the nursing
b b b b b b b b b b b b b
process do these actions illustrate?
b b b b b
a. Nursing diagnosis b